<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39334044</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Causes and predictors of premature death in the pars cohort study, Iran: a cohort study.</ArticleTitle><Pagination><StartPage>2601</StartPage><MedlinePgn>2601</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2601</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-024-19583-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">While death in old age is inevitable, premature death at younger ages is within our control. Premature mortality (death &lt; 70 years) is a crucial indicator of health status and access to healthcare, with variations observed across regions. In North Africa and the Middle East, ischemic heart disease (IHD), road injuries, stroke, and chronic kidney disease are projected to be the main causes of premature mortality. Unfortunately, few studies have been conducted on premature mortality worldwide. This study aimed to analyze the causes of premature death and associated risk factors within the Pars Cohort Study.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The Pars Cohort Study is a prospective cohort study conducted in Fars Province, Iran, involving 9,264 individuals aged 40-75 years, 53.8% of whom were women. We assessed participants from baseline (2012-2014) to 2021. The data were gathered through interviews, biological samples, and physical examinations. The causes of premature mortality, hazard ratios (HRs), and population attributable fraction (PAF) with 95% confidence intervals (95% CIs) for the variables were calculated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of 388 deaths, 54% were premature. The most common causes of premature death included IHD (40%), stroke (11%), road traffic injuries (6%), lower respiratory infections (5%), and COVID-19 (3%). The predictive factors [adjusted HRs (95% CIs)] associated with premature mortality included age [year, 1.07 (1.04, 1.10)], tobacco [1.43 (0.96, 2.11)], opium [2.12 (1.39, 3.24)], hypertension [1.52 (1.10, 2.12)], waist circumference [cm, 1.03 (1.00, 1.05)], female sex [0.30 (0.19, 0.47)], education [&gt; 8 years vs. no formal schooling, 0.46 (0.24, 0.88)], being married [0.60 (0.37, 0.97)], physical activity [3rd vs. 1st tertile, 0.38 (0.26, 0.57)], hip circumference [cm, 0.96 (0.92, 0.99)], estimated GFR [mL/min/1.73 m², 0.99 (0.978, 0.999)], and wealth score [4th vs. 1st quartile, 0.54 (0.32, 0.90)]. The PAF (95% CI) for all modifiable predictors was 0.83 (0.62, 0.92).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The predominant causes of premature mortality were IHD and stroke. To mitigate premature deaths, it is recommended to address both socioeconomic and behavioral factors simultaneously.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ziamanesh</LastName><ForeName>Fateme</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Digestive Disease Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sepanlou</LastName><ForeName>Sadaf G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Digestive Disease Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gandomkar</LastName><ForeName>Abdullah</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Non-Communicable Disease Research Center, Shiraz University of Medical Sciences, Shiraz, Fars, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poustchi</LastName><ForeName>Hossein</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malekzadeh</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Digestive Disease Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Non-Communicable Disease Research Center, Shiraz University of Medical Sciences, Shiraz, Fars, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malekzadeh</LastName><ForeName>Reza</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Digestive Disease Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran. malek@tums.ac.ir.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Non-Communicable Disease Research Center, Shiraz University of Medical Sciences, Shiraz, Fars, Iran. malek@tums.ac.ir.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nalini</LastName><ForeName>Mahdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Digestive Disease Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran. mahdinalini@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061213" MajorTopicYN="Y">Mortality, Premature</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="Y">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiovascular disease</Keyword><Keyword MajorTopicYN="N">Noncommunicable disease</Keyword><Keyword MajorTopicYN="N">Pars cohort study</Keyword><Keyword MajorTopicYN="N">Premature mortality</Keyword><Keyword MajorTopicYN="N">Prevention</Keyword><Keyword MajorTopicYN="N">Protective factor</Keyword><Keyword MajorTopicYN="N">Risk factor</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>0</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39334044</ArticleId><ArticleId IdType="pmc">PMC11429520</ArticleId><ArticleId IdType="doi">10.1186/s12889-024-19583-7</ArticleId><ArticleId IdType="pii">10.1186/s12889-024-19583-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen JT, Rehkopf DH, Waterman PD, Subramanian SV, Coull BA, Cohen B, et al. Mapping and measuring social disparities in premature mortality: the impact of census tract poverty within and across Boston neighborhoods, 1999–2001. J Urban Health. 2006;83(6):1063–84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3261292</ArticleId><ArticleId IdType="pubmed">17001522</ArticleId></ArticleIdList></Reference><Reference><Citation>Razeghian-Jahromi I, Ghasemi Mianrood Y, Dara M, Azami P. Premature death, underlying reasons, and preventive experiences in Iran: a narrative review. Arch Iran Med. 2023;26(7):403–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10685823</ArticleId><ArticleId IdType="pubmed">38301100</ArticleId></ArticleIdList></Reference><Reference><Citation>Peto R, Lopez AD, Norheim OF. Halving premature death. Science. 2014;345(6202):1272.</Citation><ArticleIdList><ArticleId IdType="pubmed">25214609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis J, Dowrick C, Lloyd-Williams M. The long-term impact of early parental death: lessons from a narrative study. J R Soc Med. 2013;106(2):57–67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3569022</ArticleId><ArticleId IdType="pubmed">23392851</ArticleId></ArticleIdList></Reference><Reference><Citation>Noncommunicable diseases World Health. Organisation2023 [ https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases</Citation></Reference><Reference><Citation>Ziamanesh F, Mohajeri Tehrani MR, Hemmatabadi M, Sharghi S, Fallahi B, Haghpanah V, et al. Design and implementation of a national quality registry of thyroid cancer in Iran: study protocol. Journal of Diabetes &amp; Metabolic Disorders; 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11196499</ArticleId><ArticleId IdType="pubmed">38932868</ArticleId></ArticleIdList></Reference><Reference><Citation>Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392(10159):2052–90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6227505</ArticleId><ArticleId IdType="pubmed">30340847</ArticleId></ArticleIdList></Reference><Reference><Citation>Global regional. National incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet. 2017;390(10100):1211–59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5605509</ArticleId><ArticleId IdType="pubmed">28919117</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalini M, Oranuba E, Poustchi H, Sepanlou SG, Pourshams A, Khoshnia M, et al. Causes of premature death and their associated risk factors in the Golestan Cohort Study, Iran. BMJ Open. 2018;8(7):e021479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6059279</ArticleId><ArticleId IdType="pubmed">30021753</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller DC, Murphy N, Johansson M, Ferrari P, Tsilidis KK, Boutron-Ruault M-C, et al. Modifiable causes of premature death in middle-age in Western Europe: results from the EPIC cohort study. BMC Med. 2016;14:1–11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4907105</ArticleId><ArticleId IdType="pubmed">27296932</ArticleId></ArticleIdList></Reference><Reference><Citation>Eslami A, Naghibi Irvani SS, Ramezankhani A, Fekri N, Asadi K, Azizi F, et al. Incidence and associated risk factors for premature death in the Tehran lipid and glucose study cohort, Iran. BMC Public Health. 2019;19(1):1–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6558847</ArticleId><ArticleId IdType="pubmed">31182076</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandomkar A, Poustchi H, Moini M, Moghadami M, Imanieh H, Fattahi MR, et al. Pars cohort study of non-communicable diseases in Iran: protocol and preliminary results. Int J Public Health. 2017;62(3):397–406.</Citation><ArticleIdList><ArticleId IdType="pubmed">27349480</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Physical Activity Surveillance World Health Organisation2017 [updated 24. May 2017. http://www.who.int/chp/steps/GPAQ/en/</Citation></Reference><Reference><Citation>Vinyoles E, Tafalla M, Robledo V, Marco M, Porta I, Muñoz M-A, et al. Interarm blood pressure measurement and the reference-arm assignment variability. Blood Press Monit. 2019;24(5):259–63.</Citation><ArticleIdList><ArticleId IdType="pubmed">31425157</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypertension: World Health Organization. 2023 [ https://www.who.int/news-room/fact-sheets/detail/hypertension#:~:text=Overview,get%20your%20blood%20pressure%20checked</Citation></Reference><Reference><Citation>Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–88.</Citation><ArticleIdList><ArticleId IdType="pubmed">31504418</ArticleId></ArticleIdList></Reference><Reference><Citation>Pencina KM, Thanassoulis G, Wilkins JT, Vasan RS, Navar AM, Peterson ED, et al. Trajectories of Non-HDL cholesterol across midlife: implications for Cardiovascular Prevention. J Am Coll Cardiol. 2019;74(1):70–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7346311</ArticleId><ArticleId IdType="pubmed">31272554</ArticleId></ArticleIdList></Reference><Reference><Citation>Islami F, Kamangar F, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Abedi-Ardekani B, et al. Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol. 2009;38(4):978–88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2720396</ArticleId><ArticleId IdType="pubmed">19416955</ArticleId></ArticleIdList></Reference><Reference><Citation>Doganer YC, Rohrer JE, Aydogan U, Barcin C, Cayci T, Saglam K. Association of renal function, estimated by four equations, with coronary artery disease. Int Urol Nephrol. 2015;47(4):663–71.</Citation><ArticleIdList><ArticleId IdType="pubmed">25749988</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>AZIZI F, Khalili D, Aghajani H, Esteghamati A, Hosseinpanah F, Delavari A, et al. Appropriate waist circumference cut-off points among Iranian adults: the first report of. the Iranian National Committee of Obesity; 2010.</Citation><ArticleIdList><ArticleId IdType="pubmed">20433230</ArticleId></ArticleIdList></Reference><Reference><Citation>AZIZI F, Hadaegh F, KHALILI D, Esteghamati A, HOSSEIN PF, Delavari A, et al. Appropriate definition of metabolic syndrome among Iranian adults. report of the Iranian National Committee of Obesity; 2010.</Citation><ArticleIdList><ArticleId IdType="pubmed">20804311</ArticleId></ArticleIdList></Reference><Reference><Citation>Khademi H, Etemadi A, Kamangar F, Nouraie M, Shakeri R, Abaie B, et al. Verbal autopsy: reliability and validity estimates for causes of death in the Golestan Cohort Study in Iran. PLoS ONE. 2010;5(6):e11183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2887437</ArticleId><ArticleId IdType="pubmed">20567597</ArticleId></ArticleIdList></Reference><Reference><Citation>International Statistical Classification of Diseases and Related Health Problems 10th Revision. World Health Organization [updated 25 My 2017. http://apps.who.int/classifications/icd10/browse/2016/en</Citation></Reference><Reference><Citation>WHO methods and. data sources for country-level causes of death 2000–2019 2020 [ https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods.pdf</Citation></Reference><Reference><Citation>Nalini M, Sharafkhah M, Poustchi H, Sepanlou SG, Pourshams A, Radmard AR, et al. Comparing Anthropometric indicators of visceral and General Adiposity as determinants of overall and Cardiovascular Mortality. Arch Iran Med. 2019;22(6):301–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8843234</ArticleId><ArticleId IdType="pubmed">31356096</ArticleId></ArticleIdList></Reference><Reference><Citation>Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet. 2017;390(10100):1151–210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5605883</ArticleId><ArticleId IdType="pubmed">28919116</ArticleId></ArticleIdList></Reference><Reference><Citation>Moradi-Lakeh M, Sepanlou SG, Karimi SM, Khalili N, Djalalinia S, Karimkhani C, et al. Trend of Socio-Demographic Index and Mortality Estimates in Iran and its neighbors, 1990–2015; findings of the Global Burden of diseases 2015 study. Arch Iran Med. 2017;20(7):419–28.</Citation><ArticleIdList><ArticleId IdType="pubmed">28745903</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH. Global status report on road safety 2015. World Health Organization; 2015.</Citation></Reference><Reference><Citation>Bazargan-Hejazi S, Ahmadi A, Shirazi S, Ainy E, Djalalinia S, Fereshtehnejad S-M et al. The burden of road traffic injuries in Iran and 15 surrounding countries: 1990–2016. Arch Iran Med. 2018;21(12).</Citation><ArticleIdList><ArticleId IdType="pubmed">30634852</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumacher AE, Kyu HH, Aali A, Abbafati C, Abbas J, Abbasgholizadeh R et al. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the global burden of Disease Study 2021. The Lancet. 2024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11126395</ArticleId><ArticleId IdType="pubmed">38484753</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Cardiovascular diseases fact sheet. WHO Geneva; 2017.</Citation></Reference><Reference><Citation>Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395(10226):795–808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8006904</ArticleId><ArticleId IdType="pubmed">31492503</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761–75.</Citation><ArticleIdList><ArticleId IdType="pubmed">27431356</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–52.</Citation><ArticleIdList><ArticleId IdType="pubmed">15364185</ArticleId></ArticleIdList></Reference><Reference><Citation>Khademi H, Malekzadeh R, Pourshams A, Jafari E, Salahi R, Semnani S et al. Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50 000 adults in Iran. BMJ. 2012;344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3328545</ArticleId><ArticleId IdType="pubmed">22511302</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalini M, Shakeri R, Poustchi H, Pourshams A, Etemadi A, Islami F, et al. Long-term opiate use and risk of cardiovascular mortality: results from the Golestan Cohort Study. Eur J Prev Cardiol. 2021;28(1):98–106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8133380</ArticleId><ArticleId IdType="pubmed">33624066</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamangar F, Shakeri R, Malekzadeh R, Islami F. Opium use: an emerging risk factor for cancer? Lancet Oncol. 2014;15(2):e69–77.</Citation><ArticleIdList><ArticleId IdType="pubmed">24480557</ArticleId></ArticleIdList></Reference><Reference><Citation>Malekzadeh F, Gandomkar A, Poustchi H, Etemadi A, Roshandel G, Attar A et al. Effectiveness of polypill for primary and secondary prevention of cardiovascular disease: a pragmatic cluster-randomised controlled trial (PolyPars). Heart. 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">38485210</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>